Market research
THC.AU THC Global Group Limited
AU AUD Industrials
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 44M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.35
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Industrials
- Industry
- Farm & Heavy Construction Machinery
- ISIN
- AU000000THC4
- Market cap
- 44M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.35
About
About THC Global Group Limited
THC Global Group Limited provides medicinal cannabis products to patients in Australia and internationally. The company operates through two segments, Manufacture and Distribution of Hydroponics Equipment, Materials and Nutrients; and Development and Delivery of Medicinal Cannabis. Its hydroponics products include lighting and power supplies, lighting relays and climate controls, ventilation and trimming products, extraction bags, plant rotation systems, eyewear, nutrients and accessories, etc. THC Global Group Limited has a strategic alliance with BOL Pharma-Israel; strategic partnership with Ascent Industries Corp?Canada, Sinapse and Pharma programs, and Anspec; distribution agreement with Endoca-Europe; and partnership with Medicinal Cannabis Industry Australia. The company was formerly known as The Hydroponics Company Limited and changed its name to THC Global Group Limited in November 2018. THC Global Group Limited was founded in 2016 and is based in Sydney, Australia.
Research context
THC Global Group Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Industrials
- Industry
- Farm & Heavy Construction Machinery
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the THC.AU discussion.
5 years, 6 months ago
Epsilon Healthcare Limited is currently in a long term downtrend where the price is trading 11.9% below its 200 day moving average.
From a valuation standpoint, the stock is 96.5% cheaper than other stocks from the Industrials sector with a price to sales ratio of 4.5.
Epsilon Healthcare Limited's total revenue rose by 31.2% to $3M since the same quarter in the previous year.
Its net income has increased by 6.0% to $-6M since the same quarter in the previous year.
Finally, its free cash flow fell by 2.6% to $-3M since the same quarter in the previous year.
Based on the above factors, Epsilon Healthcare Limited gets an overall score of 3/5.